Although insulin can drive each of these processes, in the context of obesity-associated NAFLD, it was recently suggested that both the insulin-mediated suppression of HGP and the induction of lipogenesis are impaired [179], but these results remained to be confirm by others. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.